CAPTRUST FINANCIAL ADVISORS - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 162 filers reported holding KARUNA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 3.11 and the average weighting 0.4%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$262,935
-19.9%
1,555
+2.7%
0.00%0.0%
Q2 2023$328,311
+3183.1%
1,514
+1746.3%
0.00%
Q2 2022$10,000
+900.0%
82
+720.0%
0.00%
Q1 2022$1,0000.0%10
+11.1%
0.00%
Q4 2021$1,0000.0%9
+12.5%
0.00%
Q3 2021$1,0000.0%80.0%0.00%
Q2 2021$1,0000.0%8
+60.0%
0.00%
Q1 2021$1,00050.00%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 797,008$134,766,08353.75%
Nan Fung Group Holdings Ltd 225,688$38,161,58430.90%
Sofinnova Investments, Inc. 1,381,149$233,538,48414.73%
First Light Asset Management, LLC 303,137$51,257,4354.87%
Altium Capital Management LP 34,000$5,749,0603.00%
DAFNA Capital Management LLC 52,873$8,940,2962.78%
Logos Global Management LP 115,000$19,445,3502.59%
GENERAL ATLANTIC, L.P. 986,710$166,842,7942.58%
MPM BioImpact LLC 53,210$8,997,2792.40%
Rock Springs Capital Management LP 505,433$85,463,6662.29%
View complete list of KARUNA THERAPEUTICS INC shareholders